GeneDx Holdings (WGS) Non-Current Debt (2020 - 2025)
Historic Non-Current Debt for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $51.6 million.
- GeneDx Holdings' Non-Current Debt fell 87.44% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 87.44%. This contributed to the annual value of $51.9 million for FY2024, which is 147.09% down from last year.
- According to the latest figures from Q3 2025, GeneDx Holdings' Non-Current Debt is $51.6 million, which was down 87.44% from $51.7 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Non-Current Debt ranged from a high of $52.7 million in Q4 2023 and a low of $6.1 million during Q3 2023
- Over the past 5 years, GeneDx Holdings' median Non-Current Debt value was $18.0 million (recorded in 2021), while the average stood at $28.0 million.
- Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 4318.18% in 2022, then surged by 75978.19% in 2024.
- Quarter analysis of 5 years shows GeneDx Holdings' Non-Current Debt stood at $11.0 million in 2021, then tumbled by 43.18% to $6.2 million in 2022, then skyrocketed by 743.01% to $52.7 million in 2023, then decreased by 1.47% to $51.9 million in 2024, then fell by 0.64% to $51.6 million in 2025.
- Its Non-Current Debt stands at $51.6 million for Q3 2025, versus $51.7 million for Q2 2025 and $51.8 million for Q1 2025.